Navigation Links
Northfield Laboratories Reports Results of Pivotal Phase III Trauma,Study

to blood, PolyHeme can play an important role in saving lives."

Conference Call

Northfield will hold a conference call today, Wednesday, May 23, 2007, at 8:30 a.m. EDT to discuss the results of the study. To participate in the call, investors may dial 866.770.7146 and reference the passcode 56877457. Investors may also access a live audio webcast at www.northfieldlabs.com; this will be archived for two weeks. A telephone replay will also be available for two weeks by dialing 888-286-8010 and entering the passcode 14789842.

Analysis Populations

The study protocol pre-specified multiple patient populations for analysis: the primary Modified Intent to Treat population (MITT); the As Treated population (AT); and the Per Protocol population (PP).

Efficacy Analysis

The primary efficacy endpoint of the study was a dual superiority-noninferiority assessment of mortality at 30 days after injury. A noninferiority endpoint requires the establishment of a relative margin around the control outcome. The margin to assess noninferiority in this study, using the upper limit of the confidence interval, was set at 7% more than control.

MITT Population

The MITT population is comprised of all 714 patients both randomized and treated. In this population, patients were analyzed as randomized, and not based on the actual treatment they received. There were 41 randomized patients in the study who received the incorrect treatment. Therefore, the 21 patients randomized to PolyHeme who did not receive any PolyHeme were analyzed in the PolyHeme group. Similarly, the 20 patients randomized to control who did receive PolyHeme were analyzed in the control group.

AT Population

The AT population is also comprised of all 714 patients both randomized and treated. However, in this population all patients were analyzed according to the treatment they actually received. Therefore, all patients who did receive PolyHeme were analyzed in
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Northfield Laboratories Investor Update
2. Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
3. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study for Milnacipran as a Treatment for Fibromyalgia Syndrome
4. Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
5. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
6. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
7. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
8. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
9. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
10. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
11. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
Post Your Comments:
(Date:1/23/2015)... Jan. 23, 2015  A new analysis of Centers for ... enrollment data shows that 81 percent of seniors chose ... extra discounts at certain pharmacies. The findings were released ... plans are now the foundation of Medicare Part D," ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
(Date:1/23/2015)... 23, 2015  Now available for sale, The Armor1 Ankle ... prevents ankle sprains by cushioning the ankle from an ... around the outside of any shoe type and allows ... still offering protection against sprains. With customers in physical ...
Breaking Medicine Technology:New Analysis: 81 Percent of Medicare Part D Seniors Choose "Preferred Pharmacy" Plans in 2015 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... Holdings, Inc. (OTC Bulletin Board: ADLS ), announced ... discussing the Company,s 2010 third quarter financial results on Friday, ... Ph.D., Chairman & Chief Executive Officer, as well as other ... on the Company. A press release reporting the 2010 third ...
... 2010 Neuraltus Pharmaceuticals, a privately held biopharmaceutical ... that address critical unmet needs, primarily in the ... was awarded three grants totaling $733,437 ... (QTDP).  The grants are being provided under section ...
Cached Medicine Technology:Advanced Life Sciences to Host 2010 Third Quarter Financial Results Conference Call and Webcast 2Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP) 2Neuraltus Pharmaceuticals Awarded $733,437 Under the Qualifying Therapeutic Discovery Projects Grant Program (QTDP) 3
(Date:1/22/2015)... (PRWEB) January 22, 2015 Blue Cross and ... Minnesotans who exemplify what it means to “Live Fearless.” ... for people to share their stories about how they or ... simply inspired others by living in the moment. By telling ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... 22, 2015 Lower-Auto-Insurance.com has released a new blog ... a car for reducing the costs of an auto insurance ... be able to get lower prices for their vehicle insurance policies. ... role in determining policy costs. Because of this, drivers should ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... Personality characteristics play a major role in determining ... research published in the November issue of the ... co-authored by University of Minnesota psychology professor Deniz ... through their seven-year medical school career, investigating which ...
... 450 Deaths a ... , ... NY and Washington, DC (Vocus) December 3, 2009 -- The Measles Initiative announced today that ... in 2000 to 164 000 in 2008. However, global immunization experts warn of a resurgence ...
... ... production work and 5 awards for post production services. , ... (PRWEB) December 3, 2009 -- The 13th ... Press Club in Washington, D.C. last week. Henninger Media Services (“Henninger”) capped off ...
... , Diabetes: A Deeper ... Experience for All Ages , DETROIT, Dec. 3 In ... On December 5, 2009, the Detroit Science Center will debut its newest ... the public might have about diabetes, diabetes treatment and the role insulin ...
... , , WASHINGTON, ... that there is "hopeful news" for patients who are struggling financially ... for Prescription Assistance ( PPA ) has helped more than ... nearly free. , The Partnership for Prescription Assistance has access ...
... solid organ transplants have been issued with expert advice to ... global H1N1 (swine flu) pandemic. The paper, published ... urges them to stay alert to the significant concerns that ... bird flu (H5N1), to develop into a strain with unpredictable ...
Cached Medicine News:Health News:Personality predicts success in medical school, says new study by U of Minnesota professor 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4Health News:Henninger Media Services Wins 9 TIVA Peer Awards 2Health News:Henninger Media Services Wins 9 TIVA Peer Awards 3Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 2Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 3Health News:Interactive Traveling Diabetes Exhibit to Be Unveiled at Detroit Science Center 4Health News:Transplant infectious disease experts provide pandemic guidance 2Health News:Transplant infectious disease experts provide pandemic guidance 3
... care., ,The S/5 FM is the newest ... line., ,The S/5 FM has a modular ... The new Patient Side Module (PSM) includes a ... 12-lead ECG, NIBP, motion-tolerant SpO 2 , 2 ...
... Flexible, modular, easy to use., ... a modular, small-footprint monitor ideally suited for ... S/5 measurement modules and Datex-Ohmeda supplies and ... Monitor shares the same user interface and ...
Anesthetists Precordial Kit incudes one set of 4 chromed plated chest pieces, a reusable monoscope of your choice, and 20 precordial adhesive discs....
For accurately monitoring heart and breath sounds....
Medicine Products: